Answers are grounded in this paper and cite their sources.
Deregulation of the Ras/Raf/MEK/extracellular signal-regulated kinase pathway is a common event in childhood acute lymphoblastic leukemia and is caused by point mutation, gene deletion, and chromosomal translocation of a vast array of gene types, highlighting its importance in leukemia biology. Pathway activation can be therapeutically exploited and may guide new therapies needed for relapsed acute lymphoblastic leukemia and other high risk subgroups.
No takes yet. Share an insight, caveat, or question.
Knight et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: